Tired of expensive stocks being just of reach? Look abroad for some great buying opportunities.Bargain stocks are extremely difficult to come by these days. Investors have already scooped up many of these stocks during the S&P 500's monstrous 45% gain over the past 12 months.Luckily, there are still...

https://www.fool.com/investing/2021/05/07/3-more-global-value-stocks-to-buy-now/?source=iedfolrf0000001

#fool

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alphatec Holdings (ATEC), Cardiovascular Systems ...
The post Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Cardiovascular Systems (CSII) and Corcept Therapeutics (CORT) ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-alphatec-holdings-atec-cardiovascular-systems-csii-and-corcept-therapeutics-cort/

#SmarterAnalyst

Joe Biden's announcement in support of waiving COVID-19 vaccine patents has raised eyebrows in other nations with powerful pharmaceutical industries.

German Chancellor Angela Merkel.
Getty

Bidens support for waiving COVID-19 vaccine patents has had a mixed reaction from EU countries.
A ...

https://www.businessinsider.com/germany-objects-biden-support-covid-vaccine-patent-waiver-2021-5

#Insider

Theres a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Astronics (ATRO), II-VI (IIVI) and ...
The post Analysts Offer Insights on Technology Companies: Astronics (ATRO), II-VI (IIVI) and Q2 Holdings (QTWO) appeared first on Smarter Analyst.
Theres a lot to be ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-technology-companies-astronics-atro-ii-vi-iivi-and-q2-holdings-qtwo/

#SmarterAnalyst

Analysts have been eager to weigh in on the Services sector with new ratings on Maximus (MMS), Universal Technical Institute (UTI) and Peloton ...
The post Analysts Offer Insights on Services Companies: Maximus (MMS), Universal Technical Institute (UTI) and Peloton Interactive (PTON) appeared first ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-services-companies-maximus-mms-universal-technical-institute-uti-and-peloton-interactive-pton/

#SmarterAnalyst

Theres a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Wayfair (W) and Roku ...
The post Analysts Offer Insights on Consumer Goods Companies: Wayfair (W) and Roku (ROKU) appeared first on Smarter Analyst.
Theres a lot to be optimistic about in the Consumer ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-consumer-goods-companies-wayfair-w-and-roku-roku-2/

#SmarterAnalyst

In a report released yesterday, Kenneth Herbert from Canaccord Genuity maintained a Hold rating on Cubic (CUB), with a price target of $75.00.
The post Cubic (CUB) Receives a Hold from Canaccord Genuity appeared first on Smarter Analyst.
In a report released yesterday, Kenneth Herbert from Canaccord...

https://www.smarteranalyst.com/new-blurbs/cubic-cub-receives-a-hold-from-canaccord-genuity/

#SmarterAnalyst

In a report released yesterday, Kenneth Herbert from Canaccord Genuity maintained a Hold rating on Flir Systems (FLIR), with a price target of ...
The post Flir Systems (FLIR) Receives a Rating Update from a Top Analyst appeared first on Smarter Analyst.
In a report released yesterday, Kenneth ...

https://www.smarteranalyst.com/new-blurbs/flir-systems-flir-receives-a-rating-update-from-a-top-analyst/

#SmarterAnalyst

In a report released today, Mark Miller from Benchmark Co. maintained a Buy rating on II-VI (IIVI), with a price target of $105.
The post II-VI (IIVI) Gets a Buy Rating from Benchmark Co. appeared first on Smarter Analyst.
In a report released today, Mark Miller from Benchmark Co. maintained a Buy ...

https://www.smarteranalyst.com/new-blurbs/ii-vi-iivi-gets-a-buy-rating-from-benchmark-co/

#SmarterAnalyst

Canaccord Genuity analyst Kyle Rose maintained a Buy rating on Insulet (PODD) yesterday and set a price target of $280.00.
The post Insulet (PODD) Receives a Buy from Canaccord Genuity appeared first on Smarter Analyst.
Canaccord Genuity analyst Kyle Rose maintained a Buy rating on Insulet (PODD) ...

https://www.smarteranalyst.com/new-blurbs/insulet-podd-receives-a-buy-from-canaccord-genuity/

#SmarterAnalyst

In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Misonix (MSON), with a price target of $23.00.
The post Misonix (MSON) Receives a Buy from Canaccord Genuity appeared first on Smarter Analyst.
In a report released yesterday, Kyle Rose from Canaccord Genuity...

https://www.smarteranalyst.com/new-blurbs/misonix-mson-receives-a-buy-from-canaccord-genuity-3/

#SmarterAnalyst

Canaccord Genuity analyst John Newman maintained a Buy rating on Regeneron (REGN) yesterday and set a price target of $700.00.
The post Canaccord Genuity Maintains a Buy Rating on Regeneron (REGN) appeared first on Smarter Analyst.
Canaccord Genuity analyst John Newman maintained a Buy rating on ...

https://www.smarteranalyst.com/new-blurbs/canaccord-genuity-maintains-a-buy-rating-on-regeneron-regn/

#SmarterAnalyst

H.C.
The post H.C. Wainwright Thinks Epizymes Stock is Going to Recover appeared first on Smarter Analyst.
H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Epizyme (EPZM) today and set a price target of $36.00. The companys shares closed last Thursday at $6.81, close to its 52-week low...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-thinks-epizymes-stock-is-going-to-recover/

#SmarterAnalyst

In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on Bluebird Bio (BLUE), with a price target of ...
The post Bluebird Bio (BLUE) Receives a Buy from Canaccord Genuity appeared first on Smarter Analyst.
In a report released yesterday, John Newman from ...

https://www.smarteranalyst.com/new-blurbs/bluebird-bio-blue-receives-a-buy-from-canaccord-genuity-2/

#SmarterAnalyst

After Leerink Partners and Oppenheimer gave Aldeyra Therapeutics (NASDAQ: ALDX) a Buy rating last month, the company received another Buy, this time from ...
The post Aldeyra Therapeutics (ALDX) Received its Third Buy in a Row appeared first on Smarter Analyst.
After Leerink Partners and Oppenheimer...

https://www.smarteranalyst.com/new-blurbs/aldeyra-therapeutics-aldx-received-its-third-buy-in-a-row-3/

#SmarterAnalyst

In a report released yesterday, Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Zynerba Pharmaceuticals (ZYNE), with a price target of ...
The post Canaccord Genuity Thinks Zynerba Pharmaceuticals Stock is Going to Recover appeared first on Smarter Analyst.
In a report released ...

https://www.smarteranalyst.com/new-blurbs/canaccord-genuity-thinks-zynerba-pharmaceuticals-stock-is-going-to-recover-3/

#SmarterAnalyst

In a report released yesterday, Joseph Vafi from Canaccord Genuity maintained a Buy rating on Square (SQ), with a price target of $280.00.
The post Square (SQ): New Buy Recommendation for This Technology Giant appeared first on Smarter Analyst.
In a report released yesterday, Joseph Vafi from ...

https://www.smarteranalyst.com/new-blurbs/square-sq-new-buy-recommendation-for-this-technology-giant/

#SmarterAnalyst

In a report released today, Andrew Fein from H.C.
The post H.C. Wainwright Keeps a Buy Rating on Merus (MRUS) appeared first on Smarter Analyst.
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Merus (MRUS), with a price target of $30.00. The companys shares ...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-keeps-a-buy-rating-on-merus-mrus/

#SmarterAnalyst

Canaccord Genuity analyst Maria Ripps maintained a Buy rating on Blue Apron Holdings (APRN) yesterday and set a price target of $12.00.
The post Canaccord Genuity Thinks Blue Apron Holdings Stock is Going to Recover appeared first on Smarter Analyst.
Canaccord Genuity analyst Maria Ripps maintained ...

https://www.smarteranalyst.com/new-blurbs/canaccord-genuity-thinks-blue-apron-holdings-stock-is-going-to-recover/

#SmarterAnalyst

Canaccord Genuity analyst Richard Close maintained a Buy rating on AdaptHealth (AHCO) yesterday and set a price target of $44.00.
The post Canaccord Genuity Sticks to Its Buy Rating for AdaptHealth (AHCO) appeared first on Smarter Analyst.
Canaccord Genuity analyst Richard Close maintained a Buy ...

https://www.smarteranalyst.com/new-blurbs/canaccord-genuity-sticks-to-its-buy-rating-for-adapthealth-ahco/

#SmarterAnalyst

In a report released today, David Hynes from Canaccord Genuity maintained a Buy rating on Dropbox (DBX), with a price target of $30.00.
The post Canaccord Genuity Maintains a Buy Rating on Dropbox (DBX) appeared first on Smarter Analyst.
In a report released today, David Hynes from Canaccord Genuity...

https://www.smarteranalyst.com/new-blurbs/canaccord-genuity-maintains-a-buy-rating-on-dropbox-dbx/

#SmarterAnalyst

Home decor superstore At Home Group Inc. (HOME) has agreed to be acquired by private equity firm Hellman and Friedman (H&F) for a ...
The post H&F To Buy At Home For $2.8B; Investors To Receive $36 Per Share appeared first on Smarter Analyst.

Home decor superstore At Home Group Inc. (HOME) has ...

https://www.smarteranalyst.com/stock-news/h-investors-to-receive-36-per-share/

#SmarterAnalyst

In a report released yesterday, Jonathan Dorsheimer from Canaccord Genuity maintained a Buy rating on nLIGHT (LASR), with a price target of $38.00.
The post Canaccord Genuity Reaffirms Their Buy Rating on nLIGHT (LASR) appeared first on Smarter Analyst.
In a report released yesterday, Jonathan ...

https://www.smarteranalyst.com/new-blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-nlight-lasr/

#SmarterAnalyst

In a report released today, David Hynes from Canaccord Genuity maintained a Buy rating on Avalara (AVLR), with a price target of $165.00.
The post Canaccord Genuity Keeps Their Buy Rating on Avalara (AVLR) appeared first on Smarter Analyst.
In a report released today, David Hynes from Canaccord ...

https://www.smarteranalyst.com/new-blurbs/canaccord-genuity-keeps-their-buy-rating-on-avalara-avlr/

#SmarterAnalyst

Canaccord Genuity analyst Joseph Vafi maintained a Buy rating on Grid Dynamics Holdings (GDYN) yesterday and set a price target of $20.00.
The post Grid Dynamics Holdings (GDYN) Gets a Buy Rating from Canaccord Genuity appeared first on Smarter Analyst.
Canaccord Genuity analyst Joseph Vafi ...

https://www.smarteranalyst.com/new-blurbs/grid-dynamics-holdings-gdyn-gets-a-buy-rating-from-canaccord-genuity-3/

#SmarterAnalyst

In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on Allogene Therapeutics (ALLO), with a price target of ...
The post Canaccord Genuity Thinks Allogene Therapeutics Stock is Going to Recover appeared first on Smarter Analyst.
In a report released yesterday, ...

https://www.smarteranalyst.com/new-blurbs/canaccord-genuity-thinks-allogene-therapeutics-stock-is-going-to-recover/

#SmarterAnalyst

H.C.
The post H.C. Wainwright Sticks to Its Buy Rating for Alector (ALEC) appeared first on Smarter Analyst.
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Alector (ALEC) today and set a price target of $41.00. The companys shares closed last Thursday at $16.97.
According to TipRanks...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-alector-alec/

#SmarterAnalyst

H.C.
The post H.C. Wainwright Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC) appeared first on Smarter Analyst.
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Fulcrum Therapeutics (FULC) today and set a price target of $20.00. The companys shares closed last Thursday at $...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-fulcrum-therapeutics-fulc/

#SmarterAnalyst

The UK upgraded its policy of offering those under 30 an alternative to the Oxford-AstraZeneca vaccine.

A vial of the Oxford University/AstraZeneca COVID-19 vaccine.
Steve Parsons/Pool Photo via AP

The UK is offering everyone under 40 an alternative to the AstraZeneca COVID-19 vaccine, citing ...

https://www.businessinsider.com/coronavirus-uk-offer-under-40s-astrazeneca-vaccine-alternative-2021-5

#Insider

Canaccord Genuity analyst David Hynes maintained a Hold rating on Bill.com Holdings (BILL) today and set a price target of $150.
The post Bill.com Holdings (BILL) Receives a Hold from Canaccord Genuity appeared first on Smarter Analyst.
Canaccord Genuity analyst David Hynes maintained a Hold rating ...

https://www.smarteranalyst.com/new-blurbs/bill-com-holdings-bill-receives-a-hold-from-canaccord-genuity/

#SmarterAnalyst

One company is setting itself apart in a crowded field.Long before they won the 2020 Nobel Prize in Chemistry for discovering the molecular gene-editing tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9,Jennifer Doudna and Emmanuelle Charpentier dreamed of ...

https://www.fool.com/investing/2021/05/07/with-1-cure-behind-it-this-breakthrough-biotech-ta/?source=iedfolrf0000001

#fool

In a report released today, Andrew Fein from H.C.
The post H.C. Wainwright Reaffirms Their Buy Rating on Keros Therapeutics (KROS) appeared first on Smarter Analyst.
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Keros Therapeutics (KROS), with a price target...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-keros-therapeutics-kros/

#SmarterAnalyst

In a report released today, Andrew Fein from H.C.
The post Kymera Therapeutics (KYMR) Gets a Buy Rating from H.C. Wainwright appeared first on Smarter Analyst.
In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Kymera Therapeutics (KYMR), with a price target of $...

https://www.smarteranalyst.com/new-blurbs/kymera-therapeutics-kymr-gets-a-buy-rating-from-h-c-wainwright/

#SmarterAnalyst

Canaccord Genuity analyst David Hynes maintained a Buy rating on DigitalOcean Holdings (DOCN) yesterday and set a price target of $55.00.
The post DigitalOcean Holdings (DOCN) Receives a Buy from Canaccord Genuity appeared first on Smarter Analyst.
Canaccord Genuity analyst David Hynes maintained a ...

https://www.smarteranalyst.com/new-blurbs/digitalocean-holdings-docn-receives-a-buy-from-canaccord-genuity/

#SmarterAnalyst

Oscar winner Helen Mirren is helping Italys COVID-19 vaccination effort by appearing in a side-splitting video titled La Vacinada, shot with top comic Checco Zalone, that has gone viral, scoring more than 2.7 million views. In the video, Mirren is doing some gardening on a roadside in ...

https://variety.com/2021/digital/news/helen-mirren-italy-vaccination-la-vacinada-1234968630/

#variety

The sectors that were hardest hit by the pandemic, such as travel, are rapidly improving as the economy bounces back, Goldman Sachs said.

The US economy is reopening and growing rapidly.
Charlie Riedel/AP

Americans are upping their spending on travel as the economy recovers, Goldman Sachs said.
...

https://www.businessinsider.com/us-economy-covid-rebound-consumer-spending-travel-vaccines-goldman-sachs-2021-5

#Insider

Safer transport modes during the COVID-19 crisis have become critical to ensure the aspirations of the emerging region as well as its economy...

https://www.financialexpress.com/infrastructure/airlines-aviation/air-connectivity-boost-under-udan-rupsi-airport-in-assam-to-start-operations-from-saturday/2247794/

#TheFinancialExpress

KUALA LUMPUR, May 7 Continuous buying support in selected healthcare, industrial products and services counters pushed Bursa Malaysia to end the week on a positive note, with its benchmark index rising 0.58 per cent. At 5pm, the benchmark index...

A general view inside the RHB Centre stock market ...

https://www.malaymail.com/news/money/2021/05/07/bursa-malaysia-settles-the-week-on-positive-note/1972476

#TheMalayMailMoney

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arena Pharma (ARNA), Coherus Biosciences ...
The post Analysts Offer Insights on Healthcare Companies: Arena Pharma (ARNA), Coherus Biosciences (CHRS) and Chemomab Therapeutics (CMMB) appeared first on ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-arena-pharma-arna-coherus-biosciences-chrs-and-chemomab-therapeutics-cmmb/

#SmarterAnalyst

Welcome to Ad Age---s Wake-Up Call, our daily roundup of advertising, marketing, media and digital news. If you're reading this online or in a forwarded email, here's the link to sign up for our Wake-Up Call newsletters. Departure lounge

Thursday saw high-profile departures from both the client--...

https://adage.com/article/news/high-profile-departures-general-mills-and-ogilvy-and-lessons-pelotons-recall-friday-wake-call/2334056

#adage

H.C.
The post Arrowhead Pharmaceuticals (ARWR) Receives a Buy from H.C. Wainwright appeared first on Smarter Analyst.
H.C. Wainwright analyst Patrick Trucchio maintained a Buy rating on Arrowhead Pharmaceuticals (ARWR) today and set a price target of $95.00. The companys shares closed last Thursday ...

https://www.smarteranalyst.com/new-blurbs/arrowhead-pharmaceuticals-arwr-receives-a-buy-from-h-c-wainwright/

#SmarterAnalyst

H.C.
The post Sangamo Biosciences (SGMO) Receives a Buy from H.C. Wainwright appeared first on Smarter Analyst.
H.C. Wainwright analyst Patrick Trucchio maintained a Buy rating on Sangamo Biosciences (SGMO) today and set a price target of $25.00. The companys shares closed last Thursday at $10.40.
...

https://www.smarteranalyst.com/new-blurbs/sangamo-biosciences-sgmo-receives-a-buy-from-h-c-wainwright/

#SmarterAnalyst

H.C.
The post TherapeuticsMD (TXMD) Gets a Buy Rating from H.C. Wainwright appeared first on Smarter Analyst.
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on TherapeuticsMD (TXMD) today and set a price target of $4.00. The companys shares closed last Thursday at $1.11, close to its ...

https://www.smarteranalyst.com/new-blurbs/therapeuticsmd-txmd-gets-a-buy-rating-from-h-c-wainwright-7/

#SmarterAnalyst

In a report released today, Douglas Tsao from H.C.
The post H.C. Wainwright Reiterates a Buy Rating on Trevena (TRVN) appeared first on Smarter Analyst.
In a report released today, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Trevena (TRVN), with a price target of $5.00. The companys...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-reiterates-a-buy-rating-on-trevena-trvn-2/

#SmarterAnalyst

H.C.
The post H.C. Wainwright Maintains Their Buy Rating on Euronav (EURN) appeared first on Smarter Analyst.
H.C. Wainwright analyst Magnus Fyhr maintained a Buy rating on Euronav (EURN) today and set a price target of $13.00. The companys shares closed last Thursday at $8.75.
According to TipRanks...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-maintains-their-buy-rating-on-euronav-eurn/

#SmarterAnalyst

H.C.
The post H.C. Wainwright Remains a Buy on International Seaways (INSW) appeared first on Smarter Analyst.
H.C. Wainwright analyst Magnus Fyhr reiterated a Buy rating on International Seaways (INSW) today and set a price target of $30.00. The companys shares closed last Thursday at $20.23.
...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-remains-a-buy-on-international-seaways-insw/

#SmarterAnalyst

In a report released today, Blair Abernethy from Rosenblatt Securities maintained a Hold rating on Datadog (DDOG), with a price target of $97.00.
The post Rosenblatt Securities Remains a Hold on Datadog (DDOG) appeared first on Smarter Analyst.
In a report released today, Blair Abernethy from ...

https://www.smarteranalyst.com/new-blurbs/rosenblatt-securities-remains-a-hold-on-datadog-ddog-2/

#SmarterAnalyst

The USD/CHF is on track for the fifth weekly loss as the Swiss economy recovers and as questions of the Federal Reserve monetary policy decisions remain. The pair dropped to 0.9075, which was the lowest level since March 1. Swiss economic recovery gaining steam The Switzerland economy is doing ...

https://invezz.com/news/2021/05/07/usd-chf-on-track-for-the-5th-weekly-decline-as-swiss-unemployment-falls/

#InvezzNews